Using Downhole Probes to Locate and Characterize Buried Transuranic and Mixed Low Level Waste

Borehole logging probes were developed and tested to locate and quantify transuranic elements in subsurface disposal areas and in contaminated sites at USDOE Weapons Complex sites. A new method of measuring very high levels of chlroine in the subsurface was developed using pulsed neutron technology from oilfield applications. The probes were demonstrated at the Hanford site in wells containing plutonium and other contaminants

Using Downhole Probes to Locate and Characterize Buried Transuranic and Mixed Low Level Waste

Borehole logging probes were developed and tested to locate and quantify transuranic elements in subsurface disposal areas and in contaminated sites at USDOE Weapons Complex sites. A new method of measuring very high levels of chlroine in the subsurface was developed using pulsed neutron technology from oilfield applications. The probes were demonstrated at the Hanford site in wells containing plutonium and other contaminants

Ex Vivo

One of the limitations for clinical applications of dendritic cell (DC)-based cancer immunotherapy is the low potency in generating tumor antigen specific T cell responses. We examined the immunotherapeutic potential of a mitochondria-targeted nanoparticle (NP) based on a biodegradable polymer and zinc phthalocyanine (ZnPc) photosensitizer (T-ZnPc-NPs). Here, we report that tumor antigens generated from treatment of breast cancer cells with T-ZnPc-NPs upon light stimulation activate DCs to produce high levels of interferon-gamma, an important cytokine considered as a product of T and natural killer cells. The remarkable ex vivo DC stimulation ability of this tumor cell supernatant is a result of an interleukin (IL)-12/IL-18 autocrine effect. These findings contribute to the understanding of how in situ light activation amplifies the host immune responses when NPs deliver the photosensitizer to the mitochondria and open up the possibility of using mitochondria-targeted-NP-treated, light-activated cancer cell supernatants as possible vaccines